ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,431Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 1006

$642K Total Retail Price of All Prescriptions

Rank: 132 out of 1006

594 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 594 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 594 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 582 521 1 1
AMLODIPINE BESYLATE 581 534 2 4
ATORVASTATIN CALCIUM 442 366 3 5
METOPROLOL TARTRATE 401 355 4 7
LISINOPRIL 344 260 5 3
LEVOTHYROXINE SODIUM 309 279 6 2
METFORMIN HCL 297 263 7 10
FUROSEMIDE 293 280 8 6
HYDROCHLOROTHIAZIDE 270 247 9 11
WARFARIN SODIUM 268 268 10 8
ALENDRONATE SODIUM 241 237 11 29
LOSARTAN POTASSIUM 224 198 12 22
DIOVAN 185 185 13 16
METOPROLOL SUCCINATE 170 158 14 12
CARVEDILOL 163 151 15 36
OMEPRAZOLE 161 147 16 9
ALLOPURINOL 158 158 17 31
GLIMEPIRIDE 154 131 18 50
PRAVASTATIN SODIUM 150 147 19 15
ATENOLOL 147 120 20 13
GABAPENTIN 144 139 21 20
DIGOXIN 136 130 22 52
LIPITOR 132 126 23 47
RAMIPRIL 116 106 24 79
CRESTOR 104 99 25 18
ISOSORBIDE MONONITRATE ER 94 85 26 59
SYNTHROID 94 94 26 42
ADVAIR DISKUS 92 81 28 37
AZITHROMYCIN 91 83 29 39
TAMSULOSIN HCL 89 89 30 23
SERTRALINE HCL 89 89 30 19
HYDROCODONE-ACETAMINOPHEN 83 69 S3 32 25
ESCITALOPRAM OXALATE 80 73 33 27
PREDNISONE 78 78 34 33
ZOLPIDEM TARTRATE 78 64 34 14
DIOVAN HCT 77 77 36 60
NEXIUM 77 73 36 28
BENICAR 75 70 38 78
PANTOPRAZOLE SODIUM 74 74 39 32
ENALAPRIL MALEATE 74 62 39 83
LOSARTAN-HYDROCHLOROTHIAZIDE 72 72 41 81
CLOPIDOGREL 71 62 42 46
LOVAZA 69 64 43 157
GLIPIZIDE XL 65 65 44 175
DONEPEZIL HCL 65 65 44 17
ACTOS 64 54 46 89
BYSTOLIC 61 61 47 84
TRICOR 60 38 48 101
CITALOPRAM HBR 58 48 49 24
NIASPAN 56 45 50 212
LOVASTATIN 56 47 50 44
PLAVIX 56 52 50 61
PROAIR HFA 54 46 53 64
ACTONEL 52 52 54 152
IRBESARTAN 52 49 54 378
PAROXETINE HCL 52 48 54 62
JANTOVEN 51 48 57 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.